MGNX ▲ +0.3% - MacroGenics, Inc.
$MGNX - MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
15-OCT-2026 04:05 PM ET
Share this post
More filings for $MGNX
MGNX ▼ -4.6% - MacroGenics, Inc.Sep 9, 2026MGNX - MacroGenics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$MGNX SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 3, 2026$MGNX SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026$MGNX SEC Filing Update (20-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 20, 2026
View full $MGNX filing history →💬 Comments
Loading comments…
Leave a comment